Market News How it works Learn FAQ
| RCT 0.1111 45.99% | NU 12.415 -18.11% | EWZ 33.695 -20.89% | TGL 0.245 10.61% | BBD 2.875 -29.36% | AZTR 1.75 144.76% | SRTM 0.3361 -21.89% | ITUB 7.655 -20.84% | NVD 3.991 -4.75% | XP 15.635 -48.59% | SHFS 0.0996 -24.77% | SOXL 92.26 10.41% | SPCX 148.545 0.72% | PBR 22.22 -15.06% | CLRO 4.77 46.77% | VALE 11.94 -3.71% | GCDT 0.1424 -19.14% | INTC 91.4822 5.20% | NWGL 0.0865 5.49% | TSLL 10.955 12.24% | CRWV 56.965 5.03% | NVDA 216.08 2.43% | SOXS 47.02 -10.37% | BITO 10.715 -1.06% | NOK 8.7457 7.44% | SGRY 23.2124 47.38% | GPUS 0.1839 8.88% | RWM 14.465 -0.58% | TSLG 5.4768 12.46% | ABEV 2.805 -15.00% | IREN 26.31 5.64% | RBNE 0.1704 -10.32% | JBLU 2.305 -12.19% | INTR 4.505 -37.34% | TQQQ 68.81 3.80% | SPDN 8.485 -0.64% | SBS 4.595 -28.20% | AAL 12.24 1.07% | QID 14.175 -2.58% | TSLA 395.14 6.16% | LUCD 0.5264 28.08% | XTND 2.0901 18.08% | SPRC 1.4801 35.79% | WULF 12.38 9.36% | NFLX 63.145 -4.11% | SID 0.9294 -21.24% | CIFR 7.995 0.69% | SQQQ 38.17 -3.81% | T 21 0.33% | PBR-A 19.54 -16.96%
VTCatheter Precision, Inc. logo

Catheter Precision, Inc. (VTAK)

New York Stock Exchange Arca · Currency in USD
$0.15 ▼ 0.00 (-0.66%)
As of Oct 2, 4:00 PM ET. Market open.

Summary

Previous Close
$0.15
Open
$0.15
Day's Range
$0.15 – $0.16
52 Week Range
$0.15 – $30.60
Volume
1,203,579
Avg. Volume
7,855,106
Market Cap
$317.40K
Beta (5Y Monthly)
0.47
PE Ratio (TTM)
--
EPS (TTM)
-$4.58
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Catheter Precision, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
17
CEO
David A. Jenkins

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures.

Earnings

Next report: Thu, Nov 12, 2026
EPS estimate -$13.30 · Revenue est. $2.80M
DateEst.Actual
Aug 17, 2026-$190.00-$0.92Beat
May 18, 2026-$20.90-$1.39Beat
Mar 31, 2026-$209.00$1.53Beat
Nov 12, 2025-$266.00-$1.70Beat
Aug 13, 2025-$34.20-$7.28Beat
May 19, 2025-$2.60-$6.81Miss

Get free alerts on VTAK and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.